Pyroptosis executive protein GSDMD as a biomarker for diagnosis and identification of Alzheimer’s disease
Abstract Objective This study was mainly conducted to explore the expression changes of GSDMD and conventional markers (including T‐Tau, Tau181p, and Aβ1–42) in the cerebrospinal fluid among patients with Alzheimer's disease (AD) and vascular dementia (VD), followed by determination of role of...
Main Authors: | Heping Shen, Chenyang Han, Yi Yang, Li Guo, Yongjia Sheng, Jin Wang, Wenyan Li, Liping Zhai, Genghuan Wang, Qiaobing Guan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-04-01
|
Series: | Brain and Behavior |
Subjects: | |
Online Access: | https://doi.org/10.1002/brb3.2063 |
Similar Items
-
Calcitriol Alleviates Hyperosmotic Stress-Induced Corneal Epithelial Cell Damage via Inhibiting the NLRP3–ASC–Caspase-1–GSDMD Pyroptosis Pathway in Dry Eye Disease
by: Zhang J, et al.
Published: (2021-07-01) -
Pyroptosis: A new frontier in cancer
by: Yuan Fang, et al.
Published: (2020-01-01) -
Pleural Fluid GSDMD Is a Novel Biomarker for the Early Differential Diagnosis of Pleural Effusion
by: Pu Li, et al.
Published: (2021-06-01) -
Agmatine Alleviates Epileptic Seizures and Hippocampal Neuronal Damage by Inhibiting Gasdermin D-Mediated Pyroptosis
by: Xueying Li, et al.
Published: (2021-08-01) -
Muscarinic acetylcholine M1 receptor regulates pyroptosis of prostate cancer cells through Caspase-1/GSDMD pathway
by: CHEN Jinying, et al.
Published: (2021-09-01)